MaryChristaKrupskiDO

PubMed

• Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-...
  Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta, Christine L Phillips, Jenna Rossoff, Heather Stefanski, Julie-An Talano, Amy ...> ;Eclinicalmedicine. 2023 Nov 1
• 1 citations
  Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of...
  Thomas J Galletta, Jeremy D Rubinstein, Christa Krupski, Adam S Nelson, Ruby Khoury, Christopher E Dandoy, Stella M Davies, Christine L Phillips> ;Pediatric Blood & Cancer. 2023 May 1
• 1 citations
  Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT.
  Ashley V Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A Pulsipher, Mary Eapen, James A Connelly, Catherine M Bollard, Sung-Yun Pai, Christine N ...> ;Blood Advances. 2023 Jul 25
• 1 citations
  HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
  Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J Chen, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine Phili...> ;Blood Advances. 2023 Jun 27
• 22 citations
  Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
  Liora M Schultz, Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K Keating, Christa Krupski, Holly Pacenta, Christine L Philips, Julie-An Talano, Amy ...> ;Journal of Clinical Oncology. 2023 Jan 10
• 20 citations
  Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
  Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Jenna Rossoff, Heather E Stefanski, Julie-An Talano, Steve P Margo...> ;Blood Advances. 2022 Jul 26
• 5 citations
  Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.
  Malika Kapadia, Leslie Lehmann, Jeffery Auletta, Lisa Beatty, Neel Bhatt, Robyn Blacken, Kathy Demmel, Therese Dodd, Catherine Desmond, Taylor Fitch, Laura Flesch, Dav...> ;Transplantation and Cellular Therapy. 2022 May 1
• 66 citations
  Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen R...
  Liora M Schultz, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Jenna Rossoff, Heather E Stefanski, Julie-An Talano, Amy Moskop, Steven P Mar...> ;Journal of Clinical Oncology. 2022 Mar 20
• 4 citations
  Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
  Jenna Rossoff, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Steven P. Margossian, Michae...> ;Blood. 2021 Nov 25
• 29 citations
  Tisagenlecleucel Outcomes in Relapsed/Refractory Extramedullary ALL: A Pediatric Real World CAR Consortium Report.
  Vanessa A Fabrizio, Christine L Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly L Pacenta, Jenna Rossoff, Heather E. Ste...> ;Blood Advances. 2021 Nov 18
• 37 citations
  Optimal fludarabine lymphodepletion is associated with improved outcomes following CAR T-cell Therapy.
  Vanessa A Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly L Pacenta, Christine L Phillips, Jenna ...> ;Blood Advances. 2021 Nov 17
• 7 citations
  Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
  Erin H. Breese, Christa Krupski, Adam S. Nelson, John P. Perentesis, Christine L Phillips> ;Journal of Pediatric Hematology/oncology. 2021 May 1
• 9 citations
  Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation
  Sharat Chandra, Shanmuganathan Chandrakasan, Blachy J. Dávila Saldaña, Jack J. Bleesing, Michael B. Jordan, Ashish R Kumar, Michael Grimley, Christa Krupski, Stella M....> ;Journal of Clinical Immunology. 2021 Jan 1
• 30 citations
  Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia.
  Jeremy D. Rubinstein, Christa Krupski, Adam S. Nelson, Maureen M. O'Brien, Stella M. Davies, Christine L Phillips> ;Biology of Blood and Marrow Transplantation. 2020 Nov 1
• 86 citations
  Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
  Pui Y. Lee, Erinn S. Kellner, Yuelong Huang, Elissa Furutani, Z. Huang, Wayne Bainter, Mohammed F. Alosaimi, Kelsey Stafstrom, Craig D. Platt, Tali Stauber, Somech Raz...> ;The Journal of Allergy and Clinical Immunology. 2020 Jun 1
• 5 citations
  CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II st...
  Pooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, Angela D. M. Kashuba, Adam Lane, Parinda A. Mehta, Rebecca A. Marsh, Michael B. Jordan, Michael Grimley, Kasia...> ;Bone Marrow Transplantation. 2020 Apr 9
• 11 citations
  High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy.
  Lynn Lee, Christa Krupski, Jason Clark, Mark Wunderlich, Robert B. Lorsbach, Michael S. Grimley, Matthew Burwinkel, Adam Nelson, Ashish R. Kumar> ;Blood Advances. 2020 Feb 25
• 11 citations
  Chimeric antigen receptor T‐cell therapy in patients with neurologic comorbidities
  Jeremy D. Rubinstein, Adam S. Nelson, Christa Krupski, William J. O'Brien, J. Michael Taylor, Tom C. Badgett, Michael Huang, Stella M. Davies, Christine L Phillips> ;Pediatric Blood & Cancer. 2020 Feb 4
• 18 citations
  Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1/IKAROS mutations.
  Erinn S. Kellner, Christa Krupski, Hye Sun Kuehn, Sergio D. Rosenzweig, Nao Yoshida, Seiji Kojima, David Boutboul, Sylvain Latour, Vincent Barlogis, Claire Galambrun, ...> ;The Journal of Allergy and Clinical Immunology. 2019 Jul 1
• 41 citations
  Late acute graft-versus-host disease: A prospective analysis of clinical outcomes and circulating angiogenic factors
  Shernan G. Holtan, Nandita Khera, John E. Levine, Xiaoyu Chai, Barry E. Storer, Hien D. Liu, Yoshihiro Inamoto, George Chen, Sebastian Mayer, Mukta Arora, Jeanne Palme...> ;Blood. 2016 Nov 10
• 15 citations
  Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead
  Christa Krupski, Madan Jagasia> ;Current Hematologic Malignancy Reports. 2015 Aug 25
• Is it time to consider early discharge for pediatric patients after hematopoietic stem cell transplant
  Christa Krupski, Jennifer Domm> ;Pediatric Transplantation. 2014 Jun 1
• 26 citations
  Maternal Cigarette Smoking and the Development of Necrotizing Enterocolitis
  Cynthia D. Downard, Stephanie N. Grant, Alexandra C. Maki, Mary C. Krupski, Paul J. Matheson, Robert W. Bendon, Mary E. Fallat, R. Neal Garrison> ;Pediatrics. 2012 Jul 1
• Join now to see all